Tuesday, April 23, 2024
Home Tags PLx

Tag: PLx

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of...

0
NEW YORK, June 07, 2021 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Protalix BioTherapeutics, Inc....

PLx Pharma Inc. Reports First Quarter 2021 Results and Provides Business...

0
– VAZALORE 325 mg and 81 mg, the first-ever novel, liquid-filled aspirin capsules, gain FDA approval – – Company secured $71.4 million of gross...

PLx Pharma Inc. Reports Fourth Quarter and Full Year 2020 Results...

0
-- Received FDA approval of sNDAs for both VAZALORE 325 mg and 81 mg, the first-ever novel, liquid-filled aspirin capsule -- ...

PLx Pharma Inc. to Discuss 2020 Fourth Quarter Financial Results on...

0
SPARTA, N.J., March 04, 2021 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), a late-stage specialty pharmaceutical...

Press Realease

Business News

Cricket

Weather News

Lifestyle

World News

UK / USA News

Local News